Targeting classical but not neurogenic inflammation reduces peritumoral oedema in secondary brain tumours-Reference-Cited by-同舟云学术

Targeting classical but not neurogenic inflammation reduces peritumoral oedema in secondary brain tumours

Published:2012-09 Issue:1-2 Volume:250 Page:59-65
ISSN:0165-5728
Container-title:Journal of Neuroimmunology
language:en
Short-container-title:Journal of Neuroimmunology

Author:

Lewis Kate M.,Harford-Wright Elizabeth,Vink Robert,Ghabriel Mounir N.

Funder

Neurosurgical Research Foundation (Australia)

Publisher

Elsevier BV

Subject

Neurology (clinical),Neurology,Immunology,Immunology and Allergy

Reference63 articles.

1. Steroid withdrawal psychosis in a patient with closed head injury;Alpert;Arch. Phys. Med. Rehabil.,1986

2. Differences in blood–tumour-barrier leakage of human intracranial tumours: quantitative monitoring of vasogenic oedema and its response to glucocorticoid treatment;Andersen;Acta Neurochir. (Wien),1998

3. Quantitation of peritumoural oedema and the effect of steroids using NMR-relaxation time imaging and blood–brain barrier analysis;Andersen;Acta Neurochir. Suppl. (Wien),1994

4. Substance P antagonist blocks leakage and reduces activation of cytokine-stimulated rat brain endothelium;Annunziata;J. Neuroimmunol.,2002

5. Ischaemic brain oedema;Ayata;J. Clin. Neurosci.,2002

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A narrative review of the principal glucocorticoids employed in cancer;Seminars in Oncology;2022-12

2. Correcting a widespread error: Neuroprotectant N-acetyl-L-tryptophan does not bind to the neurokinin-1 receptor;Molecular and Cellular Neuroscience;2022-05

3. Treatment with the NK1 Antagonist Emend Reduces Blood Brain Barrier Dysfunction and Edema Formation in an Experimental Model of Brain Tumors;PLoS ONE;2014-05-12

4. NK1 receptor antagonists and dexamethasone as anticancer agents in vitro and in a model of brain tumours secondary to breast cancer;Anti-Cancer Drugs;2013-04

5. Asymmetric cell division: Implications for glioma development and treatment;Translational Neuroscience;2013-01-01